We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Pemetrexed Disodium and Erlotinib in Treating Patients With Advanced Non-Small Cell Lung Cancer or Other Solid Tumors

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00387322
Recruitment Status : Completed
First Posted : October 13, 2006
Last Update Posted : March 29, 2010
Information provided by: